Authors:
Millot, F
Suciu, S
Philippe, N
Benoit, Y
Mazingue, F
Uyttebroeck, A
Lutz, P
Mechinaud, F
Robert, A
Boutard, P
Marguerite, G
Ferster, A
Plouvier, E
Rialland, X
Behard, C
Plantaz, D
Dresse, MF
Philippet, P
Norton, L
Thyss, A
Dastugue, N
Waterkeyn, C
Vilmer, E
Otten, J
Citation: F. Millot et al., Value of high-dose cytarabine during interval therapy of a Berlin-Frankfurt-Munster-based protocol in increased risk children with acute lymphoblastic leukemia and lymphoblastic lymphoma: Results of the European Organizationfor Research and Treatment of Cancer 58881 Randomized Phase III Trial, J CL ONCOL, 19(7), 2000, pp. 1935-1942
Authors:
Mabro, M
Cohn, R
Zanesco, L
Madon, E
Hahlen, K
Marguerite, G
Breatnach, F
Gentet, JC
Plouvier, E
Citation: M. Mabro et al., Oral granisetron solution as prophylaxis for chemotherapy-induced emesis in children: double-blind study of two doses, B CANCER, 87(3), 2000, pp. 259-264
Authors:
Ferster, A
Benoit, Y
Francotte, N
Dresse, MF
Uyttebroeck, A
Plouvier, E
Thyss, A
Lutz, P
Marguerite, G
Behar, C
Mazingue, F
Boutard, P
Millot, F
Rialland, X
Mechinaud, F
Norton, L
Robert, A
Otten, J
Vilmer, E
Philippe, N
Waterkeyn, C
Suciu, S
Citation: A. Ferster et al., Treatment outcome in infant acute lymphoblastic leukemia, BLOOD, 95(8), 2000, pp. 2729-2730
Citation: D. Kayser et al., Delivery by a Tec 6 (TM) vaporizer of desflurane vapour above the dialled-in concentration., ANN FR A R, 18(6), 1999, pp. 691-693